Neonatal mortality
Conditions
Interventions
This is a factorial cluster randomised controlled trial involving 60 village development committee clusters.
Female Community Health Volunteers will be supported in convening monthly
Sponsors
University College London (UCL) Centre for International Health and Development (UK)
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Main target population: 1. Women of reproductive age, of whom there are 140,000 2. Infants under a year of age, of whom there are 19,000 3. 26,000 pregnancies expected annually in the district Key participants: Women who either join community groups or have a pregnancy. The women's group intervention involves social mobilisation and group membership and activities will not be restricted to women of reproductive age. Since the aim is to improve the situation of pregnant women and their newborn infants, any participant who may affect this situation may be involved. Particular stakeholders may be older women, male community members, health workers and local opinion formers. All women and their newborn infants will be eligible to participate in the data collection exercise, for which enrolment will occur either during pregnancy or in the post-natal period.
Exclusion criteria
Exclusion criteria: Does not meet the inclusion criteria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neonatal mortality rates. Outcome measures are collected prospectively on an ongoing basis, so no specific timepoints for measurement. However, for the purposes of analysis of the trial, we will look at both primary and secondary outcome measures annually for 3 years. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Community groups: 1.1. Care practices and health care seeking behaviour 2. Stillbirth rates 3. Maternal mortality ratios 2. Sepsis management: 2.1. Identification and treatment of neonatal sepsis by community health volunteers 2.2. Causes of death assessed by community verbal autopsy Outcome measures are collected prospectively on an ongoing basis, so no specific timepoints for measurement. However, for the purposes of analysis of the trial, we will look at both primary and secondary outcome measures annually for 3 years. | — |
Countries
Nepal
Outcome results
None listed